Influence of Constipation in the Behavior of Circulating Alpha- and Beta-CGRP Levels in Chronic/High-Frequency Migraine Patients After CGRP Monoclonal Antibodies

<b>Background/Objectives</b>: Migraines contain neurological and gastrointestinal manifestations. The first specific migraine preventive drugs, CGRP monoclonal antibodies (mAbs), though efficacious and very well-tolerated in general, induce constipation as their main adverse event. Our g...

詳細記述

書誌詳細

出版年:	Biomedicines
主要な著者:	Gabriel Gárate, Marcos Polanco, Jorge Madera, María Muñoz-San Martín, Marta Pascual-Mato, Vicente González-Quintanilla, Julio Pascual
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2025-05-01
主題:	alpha-CGRP beta-CGRP chronic migraine constipation CGRP monoclonal antibodies high-frequency episodic migraine
オンライン･アクセス:	https://www.mdpi.com/2227-9059/13/5/1254